Briovad
Payments companies reported to CMS as associated with Briovad. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Briovad, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Briovad
These are the largest totals companies reported as associated with Briovad. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| James Long | Oklahoma City, OK | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $586,071.00 |
| Zhen-Yu Tong | Cleveland, OH | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $12,000.00 |
| John Vega | Atlanta, GA | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $6,300.00 |
| Jeffrey Teuteberg | Stanford, CA | Advanced Heart Failure and Transplant Cardiology | $6,250.00 |
| John Ransom | Little Rock, AR | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $5,077.03 |
| Howard Eisen | Hershey, PA | Advanced Heart Failure and Transplant Cardiology | $5,000.00 |
| William Holman | Birmingham, AL | Vascular Surgery | $5,000.00 |
| Zi Jian Xu | Sacramento, CA | Advanced Heart Failure and Transplant Cardiology | $4,500.00 |
| Joshua Willey | New York, NY | Neurology (Psychiatry & Neurology) | $3,675.00 |
| Cameron Wolfe | Durham, NC | Infectious Disease | $2,450.00 |
Prescribed Briovad?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.